• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rspo1/Rspo3-LGR4 信号通过 AMPKα-SREBP2 通路抑制肝内胆固醇合成。

Rspo1/Rspo3-LGR4 signaling inhibits hepatic cholesterol synthesis through the AMPKα-SREBP2 pathway.

机构信息

School of Basic Medical Sciences, Peking University, Beijing, China.

Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.

出版信息

FASEB J. 2020 Nov;34(11):14946-14959. doi: 10.1096/fj.202001234R. Epub 2020 Sep 14.

DOI:10.1096/fj.202001234R
PMID:32926477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016451/
Abstract

R-spondins (Rspos) are endogenous ligands of leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4). Rspos-LGR4 signaling plays important roles in embryogenesis, gastrointestinal homeostasis, and food intake. Here, we investigated the impacts of Rspos-LGR4 on hepatic cholesterol synthesis. Rspo1/3 and Lgr4 knockdown mice were used to investigate the impacts of Rspo1/3-LGR4 on hepatic cholesterol synthesis. AMPKα agonist, antagonist, and shRNA were used to explore the downstream targets of Rspos-LGR4 signaling. In our study, we reported that LGR4, Rspo1, and Rspo3 were highly expressed in hepatocytes and their expressions were sensitive to energy states. Rspo1 and Rspo3 reversed OA-induced cholesterol synthesis, accompanying with increased the phosphorylation of AMPKα Thr172, reduced SREBP2 nuclear translocation, and Srebf2 mRNA expression. Conversely, hepatic LGR4 knockdown increased hepatic cholesterol synthesis and decreased the phosphorylation of AMPKα both in vitro and in vivo. Activation or inhibition of AMPKα significantly abolished the effects of LGR4 deficiency or Rspos, respectively, on cholesterol synthesis. Knockdown of AMPKα1 or/and AMPKα2 repressed Rspos-induced inhibition on cholesterol synthesis. Our study indicates that Rspo1/Rspo3-LGR4 signaling in hepatocytes suppresses cholesterol synthesis via the AMPKα-SREBP2 pathway.

摘要

R 螺旋结构域蛋白(Rspos)是富含亮氨酸重复的 G 蛋白偶联受体 4(LGR4)的内源性配体。Rspos-LGR4 信号在胚胎发生、胃肠道稳态和食物摄入中发挥重要作用。在这里,我们研究了 Rspos-LGR4 对肝脏胆固醇合成的影响。使用 Rspo1/3 和 Lgr4 敲低小鼠来研究 Rspo1/3-LGR4 对肝脏胆固醇合成的影响。使用 AMPKα 激动剂、拮抗剂和 shRNA 来探索 Rspos-LGR4 信号的下游靶点。在我们的研究中,我们报告 LGR4、Rspo1 和 Rspo3 在肝细胞中高表达,其表达对能量状态敏感。Rspo1 和 Rspo3 逆转 OA 诱导的胆固醇合成,伴随着 AMPKα Thr172 的磷酸化增加、SREBP2 核易位减少和 Srebf2 mRNA 表达降低。相反,肝 LGR4 敲低在体外和体内均增加了肝胆固醇合成并降低了 AMPKα 的磷酸化。AMPKα 的激活或抑制分别显著消除了 LGR4 缺失或 Rspos 对胆固醇合成的影响。AMPKα1 和/或 AMPKα2 的敲低抑制了 Rspos 诱导的胆固醇合成抑制。我们的研究表明,肝细胞中的 Rspo1/Rspo3-LGR4 信号通过 AMPKα-SREBP2 途径抑制胆固醇合成。

相似文献

1
Rspo1/Rspo3-LGR4 signaling inhibits hepatic cholesterol synthesis through the AMPKα-SREBP2 pathway.Rspo1/Rspo3-LGR4 信号通过 AMPKα-SREBP2 通路抑制肝内胆固醇合成。
FASEB J. 2020 Nov;34(11):14946-14959. doi: 10.1096/fj.202001234R. Epub 2020 Sep 14.
2
R-spondin3-LGR4 signaling protects hepatocytes against DMOG-induced hypoxia/reoxygenation injury through activating β-catenin.R-spondin3-LGR4信号通路通过激活β-连环蛋白保护肝细胞免受DMOG诱导的缺氧/复氧损伤。
Biochem Biophys Res Commun. 2018 Apr 30;499(1):59-65. doi: 10.1016/j.bbrc.2018.03.126. Epub 2018 Mar 19.
3
LGR4 protects hepatocytes from injury in mouse.LGR4 保护小鼠肝细胞免受损伤。
Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G123-G131. doi: 10.1152/ajpgi.00056.2018. Epub 2018 Nov 8.
4
LGR4 and its ligands, R-spondin 1 and R-spondin 3, regulate food intake in the hypothalamus of male rats.LGR4 及其配体 R 型分泌蛋白 1 和 R 型分泌蛋白 3 在雄性大鼠下丘脑调节食物摄入。
Endocrinology. 2014 Feb;155(2):429-40. doi: 10.1210/en.2013-1550. Epub 2013 Nov 26.
5
Differential activities and mechanisms of the four R-spondins in potentiating Wnt/β-catenin signaling.四种 R 分泌蛋白在增强 Wnt/β-连环蛋白信号通路中的不同活性和机制。
J Biol Chem. 2018 Jun 22;293(25):9759-9769. doi: 10.1074/jbc.RA118.002743. Epub 2018 May 11.
6
Hepatic LGR4 aggravates cholestasis-induced liver injury in mice.LGR4 加剧了小鼠胆汁淤积性肝损伤。
Am J Physiol Gastrointest Liver Physiol. 2024 Apr 1;326(4):G460-G472. doi: 10.1152/ajpgi.00127.2023. Epub 2024 Mar 5.
7
Reconstitution of R-spondin:LGR4:ZNRF3 adult stem cell growth factor signaling complexes with recombinant proteins produced in Escherichia coli.使用在大肠杆菌中生产的重组蛋白重建 R- 分泌蛋白: LGR4 : ZNRF3 成年干细胞生长因子信号复合物。
Biochemistry. 2013 Oct 15;52(41):7295-304. doi: 10.1021/bi401090h. Epub 2013 Oct 3.
8
Rspo1-LGR4 axis in BMSCs protects bone against radiation-induced injury through the mTOR-dependent autophagy pathway.Rspo1-LGR4 轴通过 mTOR 依赖性自噬途径保护骨髓间充质干细胞免受辐射损伤。
J Cell Physiol. 2021 Jun;236(6):4273-4289. doi: 10.1002/jcp.30051. Epub 2021 Jan 16.
9
Structural basis for R-spondin recognition by LGR4/5/6 receptors.LGR4/5/6 受体识别 R-spondin 的结构基础。
Genes Dev. 2013 Jun 15;27(12):1339-44. doi: 10.1101/gad.219360.113. Epub 2013 Jun 11.
10
RSPO3-LGR4 Regulates Osteogenic Differentiation Of Human Adipose-Derived Stem Cells Via ERK/FGF Signalling.RSPO3-LGR4 通过 ERK/FGF 信号通路调节人脂肪干细胞的成骨分化。
Sci Rep. 2017 Feb 21;7:42841. doi: 10.1038/srep42841.

引用本文的文献

1
Polyoxometalates Ameliorate Metabolic Dysfunction-Associated Steatotic Liver Disease by Activating the AMPK Signaling Pathway.多金属氧酸盐通过激活 AMPK 信号通路改善代谢相关脂肪性肝病的肝功能障碍。
Int J Nanomedicine. 2024 Oct 25;19:10839-10856. doi: 10.2147/IJN.S485084. eCollection 2024.
2
LGR4 attenuates MGP expression and suppresses EGFR activation-induced triple-negative breast cancer metastasis.LGR4减弱骨钙素(MGP)表达并抑制表皮生长因子受体(EGFR)激活诱导的三阴性乳腺癌转移。
Am J Cancer Res. 2024 Jul 15;14(7):3419-3432. doi: 10.62347/THII9650. eCollection 2024.
3
Hepatic LGR4 aggravates cholestasis-induced liver injury in mice.LGR4 加剧了小鼠胆汁淤积性肝损伤。
Am J Physiol Gastrointest Liver Physiol. 2024 Apr 1;326(4):G460-G472. doi: 10.1152/ajpgi.00127.2023. Epub 2024 Mar 5.
4
The aminosteroid U73122 promotes oligodendrocytes generation and myelin formation.氨甾体 U73122 促进少突胶质细胞生成和髓鞘形成。
Acta Pharmacol Sin. 2024 Mar;45(3):490-501. doi: 10.1038/s41401-023-01183-7. Epub 2023 Nov 7.
5
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases.LGR4:内分泌和代谢疾病中的一种新型受体成员。
Endocr Rev. 2023 Jul 11;44(4):647-667. doi: 10.1210/endrev/bnad003.
6
Mulberry Leaf ( L.) Extracts and Its Chlorogenic Acid Isomer Component Improve Glucolipotoxicity-Induced Hepatic Lipid Accumulation via Downregulating miR-34a and Decreased Inflammation.桑叶(L.)提取物及其绿原酸异构体成分通过下调 miR-34a 和减少炎症改善糖脂毒性诱导的肝脂质堆积。
Nutrients. 2022 Nov 14;14(22):4808. doi: 10.3390/nu14224808.
7
Cistanche tubulosa phenylethanoid glycosides suppressed adipogenesis in 3T3-L1 adipocytes and improved obesity and insulin resistance in high-fat diet induced obese mice.管花肉苁蓉苯乙醇苷抑制 3T3-L1 脂肪细胞的脂肪生成,并改善高脂肪饮食诱导肥胖小鼠的肥胖和胰岛素抵抗。
BMC Complement Med Ther. 2022 Oct 13;22(1):270. doi: 10.1186/s12906-022-03743-6.
8
RSPO3 is a novel contraction-inducible factor identified in an "in vitro exercise model" using primary human myotubes.RSPO3 是在使用原代人肌管的“体外运动模型”中鉴定的一种新型收缩诱导因子。
Sci Rep. 2022 Aug 22;12(1):14291. doi: 10.1038/s41598-022-18190-z.
9
Intracellular Cholesterol Synthesis and Transport.细胞内胆固醇的合成与运输。
Front Cell Dev Biol. 2022 Mar 21;10:819281. doi: 10.3389/fcell.2022.819281. eCollection 2022.
10
Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis.LGR4在器官发育、能量代谢和癌症发生中的新作用
Front Genet. 2022 Jan 24;12:728827. doi: 10.3389/fgene.2021.728827. eCollection 2021.

本文引用的文献

1
LGR4 protects hepatocytes from injury in mouse.LGR4 保护小鼠肝细胞免受损伤。
Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G123-G131. doi: 10.1152/ajpgi.00056.2018. Epub 2018 Nov 8.
2
Glycogen synthase kinase 3β promotes liver innate immune activation by restraining AMP-activated protein kinase activation.糖原合酶激酶 3β通过抑制 AMP 激活的蛋白激酶激活促进肝脏固有免疫激活。
J Hepatol. 2018 Jul;69(1):99-109. doi: 10.1016/j.jhep.2018.01.036. Epub 2018 Feb 13.
3
Association of a gain-of-function variant in LGR4 with central obesity.LGR4中功能获得性变异与中心性肥胖的关联。
Obesity (Silver Spring). 2017 Jan;25(1):252-260. doi: 10.1002/oby.21704. Epub 2016 Dec 7.
4
Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling.鸢尾素通过AMPK-SREBP2信号通路抑制肝脏胆固醇合成。
EBioMedicine. 2016 Apr;6:139-148. doi: 10.1016/j.ebiom.2016.02.041. Epub 2016 Feb 27.
5
LGR4 and Its Role in Intestinal Protection and Energy Metabolism.LGR4 及其在肠道保护和能量代谢中的作用。
Front Endocrinol (Lausanne). 2015 Aug 25;6:131. doi: 10.3389/fendo.2015.00131. eCollection 2015.
6
Ablation of Lgr4 enhances energy adaptation in skeletal muscle via activation of Ampk/Sirt1/Pgc1α pathway.Lgr4基因敲除通过激活Ampk/Sirt1/Pgc1α信号通路增强骨骼肌的能量适应性。
Biochem Biophys Res Commun. 2015 Aug 21;464(2):396-400. doi: 10.1016/j.bbrc.2015.06.066. Epub 2015 Jun 21.
7
Statin use and non-alcoholic steatohepatitis in at risk individuals.他汀类药物的使用与高危个体的非酒精性脂肪性肝炎。
J Hepatol. 2015 Sep;63(3):705-12. doi: 10.1016/j.jhep.2015.05.006. Epub 2015 May 14.
8
AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver.AICAR诱导的AMPK激活抑制肝脏中的TSH/SREBP-2/HMGCR通路。
PLoS One. 2015 May 1;10(5):e0124951. doi: 10.1371/journal.pone.0124951. eCollection 2015.
9
The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength.R 应答蛋白家族/富含亮氨酸重复蛋白 5/环指蛋白 43 模块:Wnt 信号强度的调节剂。
Genes Dev. 2014 Feb 15;28(4):305-16. doi: 10.1101/gad.235473.113.
10
LGR4 acts as a link between the peripheral circadian clock and lipid metabolism in liver.LGR4 在肝脏的外周生物钟和脂质代谢之间起连接作用。
J Mol Endocrinol. 2014 Feb 24;52(2):133-43. doi: 10.1530/JME-13-0042. Print 2014 Apr.